Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Asthma D001249 52 associated lipids
Kidney Diseases D007674 29 associated lipids
Femoral Fractures D005264 7 associated lipids
Weight Gain D015430 101 associated lipids
Hyperemia D006940 25 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Acidosis D000138 13 associated lipids
Glioma D005910 112 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Van de Weerdt ML et al. Ketoprofen and phenylbutazone attenuation of PAF-induced lung inflammation in calves. 1999 Vet. J. pmid:10030127
Zhang J et al. [Isolation of resisting thrombus and arteriosclerosis compounds in leaves of Salix matsudana]. 1999 Zhong Yao Cai pmid:12575095
MacKay RJ et al. Effect of a conjugate of polymyxin B-dextran 70 in horses with experimentally induced endotoxemia. 1999 Am. J. Vet. Res. pmid:9918150
Fredenrich A et al. Effects of low density and high density lipoproteins isolated from non-insulin dependent diabetic patients on prostaglandin secretion by mouse macrophage cell line P388D1. 1999 Atherosclerosis pmid:9920525
Williams CA et al. The flavonoids of Tanacetum parthenium and T. vulgare and their anti-inflammatory properties. 1999 Phytochemistry pmid:10382317
Giese A et al. Thromboxane synthase regulates the migratory phenotype of human glioma cells. 1999 Neuro-oncology pmid:11550298
Tomoeda H Effects of leukocyte-depleted warm blood cardioplegia on cardiac and endothelial function. 1999 Kurume Med J pmid:10319611
Arons MM et al. Effects of ibuprofen on the physiology and survival of hypothermic sepsis. Ibuprofen in Sepsis Study Group. 1999 Crit. Care Med. pmid:10321658
Monneret G et al. Renal effects of cP450 arachidonate metabolites in the Lyon hypertensive rat. 1999 Fundam Clin Pharmacol pmid:10226768
Hanaoka M et al. Interferon-alpha elevates pulmonary blood pressure in sheep--the role of thromboxane cascade. 1999 Eur. J. Pharmacol. pmid:10323263
Chen G et al. [The effect of the molecular triggers of hemostatic activity on thrombosis in early stage of electrical injuries]. 1999 Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi pmid:11501103
Heindl B et al. The volatile anesthetic sevoflurane mitigates cardiodepressive effects of platelets in reperfused hearts. 1999 Basic Res. Cardiol. pmid:10326658
Licker M et al. Chronic angiotensin converting inhibition does not influence renal hemodynamic and function during cardiac surgery. 1999 Can J Anaesth pmid:10442956
Agnoli GC et al. Renal function and urinary prostanoid excretions in salt-depleted women: comparative effects of enalapril and indomethacin treatments. 1999 Prostaglandins Leukot. Essent. Fatty Acids pmid:10328327
Chahine R et al. The anti-thromboxane A2 synthetase activity of myocardial tissue and its variation during ischemia and reperfusion in isolated rabbit heart. 1999 Prostaglandins Leukot. Essent. Fatty Acids pmid:10328329
Peredo HA and Filinger EJ Effect of dipyridamole on prostanoid production in rat isolated atria. 1999 Prostaglandins Leukot. Essent. Fatty Acids pmid:10328333
Liguori A et al. Loop diuretics enhance the secretion of prostacyclin in vitro, in healthy persons, and in patients with chronic heart failure. 1999 Eur. J. Clin. Pharmacol. pmid:10335906
Davis KA et al. Prostanoids: early mediators in the secondary injury that develops after unilateral pulmonary contusion. 1999 J Trauma pmid:10338399
Ishihara S et al. Effects of long-term hemofiltration on circulating mediators and superoxide production during continuous endotoxin administration. 1999 J Trauma pmid:10338409
Tegeder I et al. Comparison of inhibitory effects of meloxicam and diclofenac on human thromboxane biosynthesis after single doses and at steady state. 1999 Clin. Pharmacol. Ther. pmid:10340919
Stanczyk FZ et al. Effect of oral contraceptives containing 20 and 35 micrograms ethinyl estradiol on urinary prostacyclin and thromboxane metabolite levels in smokers and nonsmokers. 1999 Contraception pmid:10342082
Mercer JB et al. The effect of short-term cold exposure on risk factors for cardiovascular disease. 1999 Thromb. Res. pmid:10418798
Gajdos M et al. [The effect of monotherapy with ciprofibrate and in combination with acetylsalicylic acid on the spectrum of lipids, thromboxane and fibrinogen in patients with atherosclerosis and hyperlipoproteinemia]. 1999 Bratisl Lek Listy pmid:10645034
Hansen JM et al. Effects of nitric oxide blockade and cyclosporin A on cardiovascular and renal function in normal man. 1999 J. Hypertens. pmid:10658936
Wang S et al. [Effects of ligustrazine on plasma platelet aggregation rate, thromboxane B2, 6-keto-prostaglandin F1 alpha and von Willebrand's factor in patients with acute onset of cor pulmonale]. 1999 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:11783174
Zhou X et al. [Clinical and experimental study on effect of Shuguan granule on mid-late rheumatoid arthritis]. 1999 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:11783301
Titos E et al. Hepatocytes are a rich source of novel aspirin-triggered 15-epi-lipoxin A(4). 1999 Am. J. Physiol. pmid:10564079
Hu Z et al. [Experimental study of influence of yiqi huoxue serial recipes on basement membrane in membranous nephritis in rabbits]. 1999 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:11783306
Reis F et al. The peripheral serotonergic system and platelet aggregation in cyclosporin A-induced hypertensive rats. 1999 Thromb. Res. pmid:10605951
Eldor A et al. A chronic hypercoagulable state in patients with beta-thalassaemia major is already present in childhood. 1999 Br. J. Haematol. pmid:10606878
Fukushima C et al. In vitro responses to antigen stimulation: comparison between human lung parenchyma resected from asthmatic patients and non-asthmatic patients. 1999 Ann. Allergy Asthma Immunol. pmid:10071522
Landoni MF et al. Enantiospecific pharmacokinetics and pharmacodynamics of ketoprofen in sheep. 1999 J. Vet. Pharmacol. Ther. pmid:10651463
Praticó D et al. Iron-dependent human platelet activation and hydroxyl radical formation: involvement of protein kinase C. 1999 Circulation pmid:10377074
Carvalho C et al. A rat model presenting eosinophilia in the airways, lung eosinophil activation, and pulmonary hyperreactivity. 1999 Exp. Lung Res. pmid:10378102
Castellani S et al. Impaired renal adaptation to stress in the elderly with isolated systolic hypertension. 1999 Hypertension pmid:10567190
Gallery ED et al. In vitro human decidual endothelial cell thromboxane secretion in preeclampsia is not abnormal. 1999 Hypertens Pregnancy pmid:10586525
Walsh SW et al. AA-2414, an antioxidant and thromboxane receptor blocker, completely inhibits peroxide-induced vasoconstriction in the human placenta. 1999 J. Pharmacol. Exp. Ther. pmid:10381779
Pavord ID et al. Induced sputum eicosanoid concentrations in asthma. 1999 Am. J. Respir. Crit. Care Med. pmid:10588604
Panara MR et al. Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects. 1999 J. Pharmacol. Exp. Ther. pmid:10381787
Freedman JE et al. Deficient platelet-derived nitric oxide and enhanced hemostasis in mice lacking the NOSIII gene. 1999 Circ. Res. pmid:10381894
Cryer B and Feldman M Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans. 1999 Gastroenterology pmid:10381905
Kubo K et al. A 21-aminosteroid, U-74006F, attenuates endotoxin-induced lung injury in awake sheep. 1999 Respirology pmid:10382236
Kohda N et al. Effect of cilostazol, a phosphodiesterase III inhibitor, on experimental thrombosis in the porcine carotid artery. 1999 Thromb. Res. pmid:10593428
Shen AY et al. Inhibition of 2-P-mercaptophenyl-1,4-naphthoquinone on human platelet function. 1999 Life Sci. pmid:10403492
Truitt A et al. Antiplatelet effects of conjugated linoleic acid isomers. 1999 Biochim. Biophys. Acta pmid:10320806
Jönsson A et al. Effects of amide local anaesthetics on eicosanoid formation in burned skin. 1999 Acta Anaesthesiol Scand pmid:10408815
Braun-Dullaeus RC et al. Cyclosporine-induced coronary artery constriction--dissociation between thromboxane release and coronary vasospasm. 1999 J. Heart Lung Transplant. pmid:10226897
Nelson DM et al. Hypoxia limits differentiation and up-regulates expression and activity of prostaglandin H synthase 2 in cultured trophoblast from term human placenta. 1999 Am. J. Obstet. Gynecol. pmid:10203658
Chakraborti T et al. Age-dependent change in arachidonic acid metabolic capacity in rat alveolar macrophages. 1999 Biochem. Mol. Biol. Int. pmid:10204087
Saareks V et al. Nicotinic acid and pyridoxine modulate arachidonic acid metabolism in vitro and ex vivo in man. 1999 Pharmacol. Toxicol. pmid:10401729
Sakamoto K et al. An imbalance in plasma prostanoids in patients with Raynaud's phenomenon and pulmonary vasospasm. 1999 Eur. Respir. J. pmid:10836338
Kanji VK et al. Vitamin E suppresses cyclosporine A-induced increase in the urinary excretion of arachidonic acid metabolites including F2-isoprostanes in the rat model. 1999 Transplant. Proc. pmid:10331052
McAdam BF et al. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. 1999 Proc. Natl. Acad. Sci. U.S.A. pmid:9874808
Mills JL et al. Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study. 1999 JAMA pmid:10432033
Mita H et al. Generation of thromboxane A2 from highly purified human sinus mast cells after immunological stimulation. 1999 Prostaglandins Leukot. Essent. Fatty Acids pmid:10359019
van Kooten F et al. Increased platelet activation in the chronic phase after cerebral ischemia and intracerebral hemorrhage. 1999 Stroke pmid:10066850
Langberg H et al. Metabolism and inflammatory mediators in the peritendinous space measured by microdialysis during intermittent isometric exercise in humans. 1999 J. Physiol. (Lond.) pmid:10066916
Takahashi H et al. Ureteral obstruction reverses glomerular proliferation in immune complex glomerulonephritis. 1999 J. Lab. Clin. Med. pmid:10072261
Fujimoto Y et al. Sphingomyelin inhibits platelet 12-lipoxygenase activity. 1999 Eur. J. Pharmacol. pmid:10478636
Hu MK et al. Synthesis and evaluation of backbone/amide-modified analogs of leualacin. 1999 Bioorg. Med. Chem. Lett. pmid:10098664
Yamamoto T et al. Production of prostanoids and nitric oxide by infarcted heart in situ and the effect of aspirin. 1999 Biochem. Biophys. Res. Commun. pmid:10198239
Yang SY and Gao ZX Determination and clinical significance of plasma levels of prostaglandins in patients with acute brain injury. 1999 Surg Neurol pmid:10511080
Takao A et al. Inhibitory effects of azelastine hydrochloride in alcohol-induced asthma. 1999 Ann. Allergy Asthma Immunol. pmid:10227338
Denizot Y et al. Are lipid mediators implicated in the production of pro- and anti-inflammatory cytokines during cardiopulmonary bypass graft with extracorporeal circulation? 1999 Cytokine pmid:10328869
Fuglsang J et al. Intravenous acetylsalicylic acid, magnesium and their combination in experimental arterial thrombosis in rats. 1999 Blood Coagul. Fibrinolysis pmid:10493216
Fruzzetti F et al. Platelet-vessel wall interactions with third-generation oral contraceptives: no evidence of detrimental effects. 1999 Thromb. Haemost. pmid:10494782
Barchasz E et al. Interleukin-1beta-induced hyperresponsiveness to [Sar9,Met(O2)11]substance P in isolated human bronchi. 1999 Eur. J. Pharmacol. pmid:10499376
Tanus-Santos JE et al. Inhaled nitric oxide improves hemodynamics during a venous air infusion (VAI) in dogs. 1999 Intensive Care Med pmid:10501756
Gurbel PA et al. Plasma thromboxane and prostacyclin are linear related and increased in patients presenting with acute myocardial infarction. 1999 Prostaglandins Leukot. Essent. Fatty Acids pmid:10477035
Li D et al. The association of diet and thrombotic risk factors in healthy male vegetarians and meat-eaters. 1999 Eur J Clin Nutr pmid:10477247
Zaitsu M et al. Induction of cytosolic phospholipase A2 and prostaglandin H2 synthase-2 by lipopolysaccharide in human polymorphonuclear leukocytes. 1999 Eur. J. Haematol. pmid:10480288
Nawarskas JJ et al. Effect of aspirin on blood pressure in hypertensive patients taking enalapril or losartan. 1999 Am. J. Hypertens. pmid:10480471
Nishimaki S and Seki K An imbalance between prostacyclin and thromboxane in relation to cerebral blood flow in neonates with maternal preeclampsia. 1999 Prostaglandins Other Lipid Mediat. pmid:10482286
Chou TC et al. Antiplatelet effect of amlodipine: a possible mechanism through a nitric oxide-mediated process. 1999 Biochem. Pharmacol. pmid:10535758
Feldman M and Cryer B Aspirin absorption rates and platelet inhibition times with 325-mg buffered aspirin tablets (chewed or swallowed intact) and with buffered aspirin solution. 1999 Am. J. Cardiol. pmid:10468077
Obata T et al. Simultaneous assay of prostaglandins and thromboxane in the cerebrospinal fluid by gas chromatography-mass spectrometry-selected ion monitoring. 1999 J. Chromatogr. B Biomed. Sci. Appl. pmid:10491991
Gust R et al. Role of cyclooxygenase-2 in oleic acid-induced acute lung injury. 1999 Am. J. Respir. Crit. Care Med. pmid:10508803
Thakur V et al. Antihypertensive effect of the combination of fosinopril and HCTZ is resistant to interference by nonsteroidal antiinflammatory drugs. 1999 Am. J. Hypertens. pmid:10509552
Sayar K and Melli M Effect of combination of misoprostol and indomethacin on eicosanoid production in carrageenan-induced air pouch inflammation in rats. 1999 Eur. J. Pharmacol. pmid:10225376
Davì G et al. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 1999 Circulation pmid:9892587
Serebruany VL et al. Effects of a novel Mac-1 inhibitor, NPC 15669, on hemostatic parameters during preconditioned myocardial infarction. 1999 Life Sci. pmid:10530802
de Meijer A et al. Meloxicam, 15 mg/day, spares platelet function in healthy volunteers. 1999 Clin. Pharmacol. Ther. pmid:10546927
Reeves JH et al. Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group. 1999 Crit. Care Med. pmid:10548188
Nosál R and Jancinová V Nonreceptor interactions in the pharmacology of blood platelets. 1999 Gen. Physiol. Biophys. pmid:10703730
Jiménez R et al. Involvement of thromboxane A2 in the endothelium-dependent contractions induced by myricetin in rat isolated aorta. 1999 Br. J. Pharmacol. pmid:10455307
Hino Y et al. Changes in endothelium-derived vascular regulatory factors during dobutamine-stress-induced silent myocardial ischemia in patients with Kawasaki disease. 1999 Jpn. Circ. J. pmid:10462014
Ogura S et al. Protective effect of tyrphostin AG-556 on shock induced by endotoxin or gram positive bacteria. 1999 Shock pmid:10446890
Brown N et al. Comparison of antiplatelet activity of microencapsulated aspirin 162.5 Mg (Caspac XL), with enteric coated aspirin 75 mg and 150 mg in patients with atherosclerosis. 1999 Br J Clin Pharmacol pmid:10383561
Itasaka H et al. The mechanism of hepatic graft protection against reperfusion injury by prostaglandin E1. 1999 Surg. Today pmid:10385367
Maitra SR et al. Alterations in hepatic gluconeogenesis, prostanoid, and intracellular calcium during sepsis. 1999 Acad Emerg Med pmid:10386675
Dahlin KL et al. Amitriptyline-induced release of endothelin-1 in isolated perfused and ventilated rat lungs. 1999 Pharmacol. Toxicol. pmid:10628905
McCowan LM et al. Administration of low-dose aspirin to mothers with small for gestational age fetuses and abnormal umbilical Doppler studies to increase birthweight: a randomised double-blind controlled trial. 1999 Br J Obstet Gynaecol pmid:10428519
Perneby C et al. Optimization of an enzyme immunoassay for 11-dehydro-thromboxane B(2) in urine: comparison with GC-MS. 1999 Thromb. Res. pmid:10632465
Dickneite G and Leithäuser B Influence of antithrombin III on coagulation and inflammation in porcine septic shock. 1999 Arterioscler. Thromb. Vasc. Biol. pmid:10364091
Spokas EG et al. Whole-blood assays for evaluation of thromboxane synthase inhibition. 1999 Methods Mol. Biol. pmid:10343321
Bode AP et al. Activation and adherence of lyophilized human platelets on canine vessel strips in the Baumgartner perfusion chamber. 1999 J. Lab. Clin. Med. pmid:9989772
Hayashi N et al. Effect of intravenous omega-6 and omega-3 fat emulsions on nitrogen retention and protein kinetics in burned rats. 1999 Nutrition pmid:9990578
Peredo HA et al. Time-course of the alterations in prostanoid production and in contractile responses of mesenteric beds isolated from streptozotocin diabetic rats. 1999 Prostaglandins Leukot. Essent. Fatty Acids pmid:10397409
Montuschi P et al. Anaphylaxis increases 8-iso-prostaglandin F2alpha release from guinea-pig lung in vitro. 1999 Eur. J. Pharmacol. pmid:9988124
Gust R et al. Response to inhaled nitric oxide in acute lung injury depends on distribution of pulmonary blood flow prior to its administration. 1999 Am. J. Respir. Crit. Care Med. pmid:9927374